Cancer Biomarkers Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)
Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031Coverage: Cancer Biomarkers Market covers analysis By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, and Others), Profiling Technology (Omics Technologies, Imaging Technologies, Immunoassays, Cytogenetics, and Bioinformatics), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Leukemia, Bladder Cancer, and Others), and Application (Prognostics, Diagnostics, Research and Development, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Report Date : Aug 2025
- Report Code : TIPBT00002663
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 193
The Cancer Biomarkers Market is expected to register a CAGR of 11.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented based on Biomarker Type (Protein Biomarkers, Genetic Biomarkers), Profiling Technology (Omics Technologies, Imaging Technologies, Immunoassays, Cytogenetics, Bioinformatics), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Leukemia, Bladder Cancer) and Application (Prognostics, Diagnostics, Research Development). The global analysis is further broken down at the regional level and major countries. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the Report
The report Cancer Biomarkers Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Cancer Biomarkers Market Segmentation
Biomarker Type
- Protein Biomarkers
- Genetic Biomarkers
Profiling Technology
- Omics Technologies
- Imaging Technologies
- Immunoassays
- Cytogenetics
- Bioinformatics
Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Leukemia
- Bladder Cancer
Application
- Prognostics
- Diagnostics
- Research Development
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Cancer Biomarkers Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Cancer Biomarkers Market Growth Drivers
- Rising Cancer Prevalence: Increased awareness and diagnosis of various cancer types fuel the demand for biomarkers.
- Advancements in Technology: Innovations in molecular biology and genomics enable the discovery and development of novel biomarkers.
- Advancements in Personalized Medicine: Advancements in personalized medicine and early cancer detection are fueling the growth of the cancer biomarkers market.
Cancer Biomarkers Market Future Trends
- Personalized Medicine: Biomarkers play a crucial role in tailoring treatment strategies for individual patients.
- Liquid Biopsy: Non-invasive techniques like blood tests for early cancer detection are gaining traction.
- Increased Focus on Early Detection and Personalized Medicine: The growing emphasis on early cancer detection and personalized treatment plans is driving the demand for cancer biomarkers.
Cancer Biomarkers Market Opportunities
- Companion Diagnostics: Biomarkers can be used to identify patients who are likely to benefit from specific therapies.
- Early Detection and Prevention: The development of biomarkers for early cancer detection and risk assessment can improve outcomes.
- Growth in Targeted Cancer Therapies: The increasing adoption of targeted therapies presents a significant opportunity for the cancer biomarkers market in personalized treatment.
Cancer Biomarkers Market Regional Insights
The regional trends and factors influencing the Cancer Biomarkers Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Cancer Biomarkers Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Cancer Biomarkers Market
Cancer Biomarkers Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ XX million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2025 - 2031) | 11.5% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Biomarker Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Cancer Biomarkers Market Players Density: Understanding Its Impact on Business Dynamics
The Cancer Biomarkers Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Cancer Biomarkers Market are:
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- Illumina, Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Cancer Biomarkers Market top key players overview
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Cancer Biomarkers Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Cancer Biomarkers Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
Frequently Asked Questions
What are the deliverable formats of the Cancer Biomarkers Market report?
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
What are the options available for the customization of this report?
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
What are the future trends of the Cancer Biomarkers Market?
The future trends of the Cancer Biomarkers Market are: Integration of AI and ML and Blockchain for secure data management
What is the expected CAGR of the Cancer Biomarkers Market?
Cancer Biomarkers Market is expected to grow at a CAGR of 11.5% between 2023-2031
What are the driving factors impacting the Cancer Biomarkers Market?
The driving factors impacting the Cancer Biomarkers Market are: Rising Cancer Prevalence and Advancements in Technology
Which are the leading players operating in the Cancer Biomarkers Market?
The leading players are: Bio Rad Laboratories Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, QIAGEN N V, Illumina Inc, Myriad Genetics Inc, Hologic Inc, Quest Diagnostics Incorporated, bioM rieux SA
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
The List of Companies
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Hologic Inc.
- Quest Diagnostics Incorporated
- bioMérieux SA
- Creative Diagnostics
Get Free Sample For